The United States Conference of Catholic Bishops (USCCB) published a document (Understanding Abortion Pills: Q & A on Chemical Abortions) to explain its concerns about the Food and Drug Administration’s (FDA) approval and deregulation of a chemical abortion pill, which is the subject of an ongoing U.S. Supreme Court case. A lawsuit filed by the pro-life…
CNA—CVS and Walgreens, the two largest pharmacy chains in the country, announced on Friday that they will begin selling the abortion pill mifepristone this month. Martin Maloney, a media representative for Walgreens, told CNA that the chain would begin distributing the pills within the next week in “select locations” in New York, Pennsylvania, Massachusetts, California…
In a nation founded on the principles of Life, Liberty and OPPORTUNITY to pursue Happiness, What are they thinking?! … CNA—An abortion-inducing drug that is used to kill preborn children up to 10 weeks gestation will stay on the market as a legal battle over the pill continues, following a decision Friday by the U.S.…
CNA—A federal judge in Texas issued a much anticipated ruling Friday that, if it holds up in court, could take the abortion drug mifepristone off pharmacy shelves due to safety concerns and in doing so prevent over half of the abortions that take place in the country. U.S. Judge Matthew Kacsmaryk’s preliminary ruling found that…
In my last post, I wrote about the change made in January by the Food & Drug Administration (FDA) to its rules regarding the dispensing of Mifepristone, the chemical abortion drug, and the intentions of Walgreens and CVS to distribute it. I am writing today with an update of that article. 21 States said “No!”…
CNA—As CVS and Walgreens continue to seek federal approval to sell an abortion drug, 20 attorneys general whose states restrict abortion warned the pharmacy chains against fulfilling mail orders within their states. What has FDA approved so far? Last month, the U.S. Food and Drug Administration (FDA) approved the sale of mifepristone through pharmacies if…
I’d like to start this article by wishing all of you a very happy 2023! Hopefully, it will prove to be more rewarding from an investment standpoint than the exceedingly disappointing 2022. Also disappointing is the recent, January 3rd, policy change by the Food and Drug Administration (FDA) that allows pharmacies to sell mifepristone. What…
The Supreme Court has overruled Roe v. Wade, holding that each state should decide its own abortion law, but there is a new battle looming over whether that extends to chemical abortions. This is no small issue when more than half of all abortions in the United States are carried out using a drug called…
